Piper Jaffray Remains Sidelined on ICU Medical (ICUI) Following Strong 2Q - PT to $119

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. WDC
3. RNG
4. BYD
5. FIX
6. SPOT
7. BE
8. NDAQ
9. TSCO
10. ORCL

Go back to Piper Jaffray Remains Sidelined on ICU Medical (ICUI) Following Strong 2Q - PT to $119

ICU Medical, Inc. Announces Second Quarter 2016 Results

August 8, 2016 4:05 PM EDT

SAN CLEMENTE, Calif., Aug. 08, 2016 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced financial results for the second quarter ended June 30, 2016.

Second Quarter 2016 Results

Second quarter 2016 revenue was $96.7 million, compared to $83.8 million in the same period last year. GAAP net income for the second quarter of 2016 was $16.6 million, or $0.98 per diluted share, as compared to GAAP net income of $13.6 million, or $0.83 per diluted share, for the second quarter of... More